Showing results (1651-1660 of 1,716) with videos related to

Sort By:
Pageof 172
Bioorganic & Medicinal Chemistry Letters|August 22, 2006
2-Aminoquinoline melanin-concentrating hormone (MCH)1R antagonistsJinlong Jiang, Myle Hoang, Jonathan R Young, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 20, 2012
The dynamic range of the human metabolome revealed by challengesSusanne Krug, Gabi Kastenmüller, Ferdinand Stückler, et al.
Genomics|May 31, 2002
Melanin-concentrating hormone receptor subtypes 1 and 2: species-specific gene expressionCarina P Tan, Hideki Sano, Hisashi Iwaasa, et al.
Cancer Research Communications|August 7, 2023
The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate CancerLucie Van Emmenis, Sheng-Yu Ku, Kaitlyn Gayvert, et al.
Clinical Oral Implants Research|February 24, 2026
Consensus Report of Group 4 of the 1st Global Consensus for Clinical Guidelines for the Rehabilitation of the Edentulous Maxilla: Conventional Dentures, Implant Overdentures and Implant-Supported Fixed Dental ProsthesesCharlotte Stilwell, Ronald E Jung, Florian Beuer, et al.
Frontiers in Pediatrics|August 16, 2021
Early Identification of Prolonged QT Interval for Prevention of Sudden Infant DeathGeorgia Sarquella-Brugada, Oscar García-Algar, María Dolores Zambrano, et al.
The Lancet. Oncology|November 23, 2015
Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trialAndreas du Bois, Gunnar Kristensen, Isabelle Ray-Coquard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2018
A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and BiomarkersHimisha Beltran, Clara Oromendia, Daniel C Danila, et al.
British Journal of Pharmacology|November 20, 2024
The endocannabinoid anandamide mediates anti-inflammatory effects through activation of NR4A nuclear receptorsTom Teichmann, Beatrice Pflüger-Müller, Virna Margarita Martín Giménez, et al.
JCI Insight|January 20, 2022
Collision tumors revealed by prospectively assessing subtype-defining molecular alterations in 904 individual prostate cancer fociJacqueline Fontugne, Peter Y Cai, Hussein Alnajar, et al.
Pageof 172